Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Emalex Biosciences
company
About
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
- 11 - 50
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $15M
- Industries
- Biopharma,Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders. The company's first development candidate Ecopipam, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome.Emalex Biosciences was founded in 2018 by Jeff Aronin.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$15M
Emalex Biosciences has raised a total of
$15M
in funding over 2 rounds. Their latest funding was raised on
Jun 3, 2020 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 3, 2020 | Debt Financing | $15M | 1 |
Horizon Technology Finance
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Emalex Biosciences is funded by 1 investors.
Horizon Technology Finance
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Horizon Technology Finance
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
